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Abstract
Integrins are  transmembrane receptors that function in key cellular processes, including cell adhesion, differentiation, and
extracellular matrix deposition through interactions with extracellular, membrane, and cytoplasmic proteins. We previously identified and
cloned a muscle 1 integrin cytoplasmic binding protein termed MIBP and found that the expression level of MIBP is critical in the
decision-making process of terminal myogenic differentiation. We report here that MIBP interacts with the 71 integrin but not the 51
integrin in C2C12 myoblasts, suggesting an important role of integrin  chains in the regulation of the 1-MIBP interaction. Furthermore,
consistent with its selective binding activity toward the 71 laminin receptor, we have found that overexpression of MIBP in C2C12
myoblasts resulted in a significant reduction of cell adhesion to laminin and inhibition of laminin matrix deposition. By contrast, neither cell
adhesion to fibronectin nor fibronectin matrix deposition was significantly altered in cells overexpressing MIBP. Finally, we show that both
the protein level and tyrosine phosphorylation of paxillin, a key signaling molecule involved in the cellular control of myogenic
differentiation, are increased by MIBP. These results suggest that MIBP functions in the control of myogenic differentiation by regulating
71 integrin-mediated cell interactions with laminin matrix and intracellular signaling through paxillin.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Myogenic differentiation is a highly regulated process
that is controlled to a large extent by cellular interactions
with extracellular matrix (Song et al., 1992; Sastry and
Horwitz, 1996; Gullberg et al., 1998; Burkin and Kaufman,
1999). The specific response of myogenic cells depends on,
among other things, the composition of the extracellular
matrix. For example, laminin promotes myogenic differen-
tiation (Foster et al., 1987), whereas fibronectin inhibits it
(Podleski et al., 1979; von der Mark and Ocalan, 1989). The
importance of laminin in muscle development and function
has been underscored by a number of clinical and experi-
mental studies showing that defects in the structure, expres-
sion, or deposition of laminin are closely associated with, or
even are the causal factors, in the pathogenesis of congenital
muscular dystrophies. For example, null- or truncation-mu-
tations in the laminin 2-chain gene result in congenital
muscular dystrophies in humans as well as in mice (Hel-
bling-Leclerc et al., 1995; Hillaire et al., 1994; Kuang et al.,
1998; Miyagoe et al., 1997; Sunada et al., 1994, 1995;
Wewer and Engvall, 1996; Xu et al., 1994). Reduction of
other laminin chains, including 1, has also been associated
with a number of cases of congenital muscular dystrophies
(Hayashi et al., 1993; Higuchi et al., 1994; Li et al., 1997;
Sewry et al., 1997; Wewer et al., 1995).
Cell adhesion to extracellular matrix is mediated by
integrins and other cell surface receptors (Hynes, 1992;
Sastry and Horwitz, 1996; Schwartz et al., 1995; Song et al.,
1992). A number of integrins, including laminin receptor
71 integrin and fibronectin receptor 51 integrin, are
expressed by myoblasts (Burkin and Kaufman, 1999; Gull-
berg et al., 1998). The expression level, subtype, and acti-
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vation state of the integrins are precisely regulated during
myogenesis (Song et al., 1992; Boettiger et al., 1995; Sastry
and Horwitz, 1996; Gullberg et al., 1998; Burkin and Kauf-
man, 1999). For example, three developmentally regulated
7 cytoplasmic domains (A, B, and C) resulting from al-
ternative RNA splicing have been identified (Collo et al.,
1993; Song et al., 1993; Ziober et al., 1993, Hodges and
Kaufman, 1996). The 7B is expressed in myoblasts as well
as in muscle fibers. In contrast, 7A and C isoforms are
expressed only after the initiation of terminal myogenic
differentiation. The 7B1 integrin plays important roles in
myogenesis (Kaufman et al., 1985; Burkin and Kaufman,
1999; Gullberg et al., 1998). It mediates cell adhesion to
laminin and participates in a number of cellular processes in
response to laminin (Burkin and Kaufman, 1999; Crawley
et al., 1997; Yao et al., 1996a). The 7B1 integrin also
participates in the formation of the postsynaptic membrane
(Burkin et al., 1998, 2000), integrin-mediated calcium sig-
naling (Kwon et al., 2000), and skeletal muscle regeneration
(Kaariainen et al., 2002). Mutations in human integrin 7
gene have been identified in patients with congenital my-
opathies (Hayashi et al., 1998). Diminished 7 expression
has also been found in laminin-related congenital muscular
dystrophies (Hodges et al., 1997; Vachon et al., 1997) and
in muscular dystrophies of unknown etiology (Pegoraro et
al., 2002). In the mouse, inactivation of the integrin 7 gene
also results in a form of muscular dystrophy (Mayer et al.,
1997). In contrast, increasing levels of the 71 integrin in
dystrophic mice ameliorates the development of muscular
dystrophy and prolongs their lifespan (Burkin et al., 2001).
These clinical and experimental studies have provided
strong evidence for crucial roles of the 71 integrin in the
pathogenesis of muscle diseases.
In addition to mediating cell adhesion to extracellular
matrix, integrins participate in myogenic differentiation by
mediating signal transduction (Sastry et al., 1996, 1999;
Kwon et al., 2000). One of the key downstream targets of
integrin signaling in myogenic differentiation is paxillin.
Increases in the protein level and tyrosine phosphorylation
of paxillin effectively inhibited terminal myogenic differ-
entiation (Sastry et al., 1999).
We recently identified a novel muscle protein termed as
MIBP that specifically interacts with the 1 integrin cyto-
plasmic domain (Li et al., 1999). The expression of MIBP
was dramatically downregulated during myogenic differen-
tiation. Furthermore, overexpression of MIBP effectively
suppressed myogenic differentiation (Li et al., 1999), sug-
gesting that the level of MIBP is crucial to the initiation of
myogenic differentiation. The particular 1 integrin recog-
nized by MIBP, however, was not known. In this study, we
show that MIBP associates with the laminin receptor
7B1 integrin but not the fibronectin receptor 51 inte-
grin. Furthermore, we have found that MIBP is functionally
involved in the regulation of cell adhesion to laminin and
laminin matrix deposition. Finally, we show that both the
protein level and tyrosine phosphorylation of paxillin are
upregulated by MIBP. These results shed light on the mech-
anism by which MIBP functions in the regulation of myo-
genic differentiation.
Materials and methods
Cells, antibodies, and other reagents
Mouse C2C12 myoblasts were from American Type
Culture Collection (Rockville, MD). Rabbit polyclonal
anti-7 cytoplasmic domain antibodies (7A2 and 7B2)
have been previously described (Song et al., 1993; Martin et
al., 1996). Rabbit polyclonal anti-5 integrin antibody
(Ab33) and anti-1 integrin antibody (MC231) were kindly
provided by Dr. John A. McDonald (Mayo Clinic, Scotts-
dale, AZ). Rabbit anti-laminin antibody was purchased from
Chemicon (Temecula, CA). Rabbit anti-entactin antibody
was kindly provided by Dr. Albert Chung (University of
Pittsburgh). Monoclonal anti-paxillin antibody and horse-
radish peroxidase (HRP)- conjugated anti-phospho-tyrosine
antibody RC-20H were purchased from BD Transduction
Laboratories (San Diego, CA). Rabbit polyclonal anti-FAK
antibody (C-20) was purchased from Santa Cruz Biotech-
nology (Santa Cruz, CA).
Cell culture and myogenic differentiation
C2C12 cells were grown in Dulbecco’s Modified Eagle’s
Medium (DMEM) supplemented with 10% fetal bovine
serum (FBS), 100 units/ml penicillin, and 100 g/ml strep-
tomycin. C2C12 cells transfected with a FLAG vector en-
coding MIBP or the control FLAG vector lacking the MIBP
sequence were grown in the same medium supplemented
with 0.5 mg/ml G418. For myogenic differentiation assays,
the cells were seeded in DMEM containing 10% FBS in
collagen-coated 24-well plates (Becton Dickinson) until
80% confluence was reached. Terminal myogenic differen-
tiation was induced by switching the medium to DMEM
containing 2% horse serum as previously described (Li et
al., 1999).
Production of CMV-7BX2-FLAG
Rat 7BX2 cDNA (Burkin et al., 1998) was subcloned in
frame into p3XFLAG-CMV14 vector (Sigma). The con-
struct was verified by DNA sequencing. C2C12 cells were
grown in Dulbecco’s medium (low glucose) containing 20%
FCS, 0.5% chick embryo extract, 2 mM glutamine, 100
units/ml penicillin, 100 g/ml streptomycin, and 10 g/ml
kanamycin. Cells were transfected with 5 g of linearized
CMV-7BX2-FLAG plasmid using Superfect Reagent
(QIAGEN Inc., Valencia, CA) following company direc-
tions. Transfected cells were grown in medium containing
500 g/ml G418 (Invitrogen Life Technology). Synthesis of
FLAG-tagged integrin 7 was confirmed by Western blot-
ting.
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Cell adhesion assay
Cell adhesion assays were performed as described
(Braut-Boucher et al., 1995). Briefly, cells (1  106) were
labeled with 10 mM Calcein-AM (Molecular Probes, Eu-
gene, OR) in OPTI- MEM medium. After incubation at
37°C in a CO2 incubator for 30 min, the cells were washed
twice with OPTI-MEM medium and seeded (6  104 cells/
well) in fibronectin- or laminin- coated 96-well plates (Bec-
ton Dickinson). Cells were incubated at 37°C in a CO2
incubator for 1 h and then the wells were washed three times
with OPTI-MEM medium. The total cells (before washing)
and the adhered cells (after washing) were quantified by
using a CytoFluor Multi- well Plate Reader (Perseptive
Biosystems, excitation wavelength  485 nm; emission
wavelength  530 nm).
Immunoprecipitation assays
Cells (as specified in each experiment) were cultured in
DMEM containing 10% FBS and harvested with a cell
scraper. For immunoprecipitation with monoclonal anti-
FLAG antibodies, cells were lysed in the lysis buffer (1%
Triton X-100 in phosphate-buffered saline containing 0.2
mM AEBSF, 10 g/ml aprotinin, 1 g/ml pepstatin A, and
5 g/ml leupeptin). The lysates were clarified by centrifu-
gation at 10,000g for 15 min and preincubated with 20 l
protein A beads. The precleared cell lysates (700 g) were
mixed with 20 l anti-FLAG antibody- conjugated beads
(M2 beads; Sigma) or the control beads (protein A–agarose
beads coupled with an irrelevant mouse IgG) and incubated
at 4°C for 1 h. The beads were washed three times with
phosphate-buffered saline. The immunoprecipitates were
analyzed by immunoblotting with anti-FLAG antibody M5,
anti-1 integrin antibody MC231, anti-7B integrin anti-
body, or anti- 5 integrin Ab33 as specified in each exper-
iment. For immunoprecipitation with anti-paxillin and anti-
FAK antibodies, cells were lysed with the RIPA buffer (20
mM Tris–HCl, pH 7.4, 150 mM NaCl, 0.5% NP-40, 1.0%
Triton X-100, 0.25% sodium deoxycholate, 30 mM sodium
pyrophosphate, 100 mM NaF, 1 mM sodium orthovanadate
and protease inhibitors). The lysates (300 g) were incu-
bated with 2 g monoclonal anti-paxillin antibody or 2 g
polyclonal anti-FAK antibody (C-20) at 4°C for 1 h, and
then mixed with protein G beads (20 l) and incubated at
4°C for another hour. The beads were pelleted by centrifu-
gation and washed with the RIPA buffer three times. The
immunoprecipitates were analyzed by immunoblotting with
monoclonal anti-paxillin antibody, anti-FAK C-20 anti-
body, or HRP conjugated anti-phosphotyrosine antibody
RC20H as specified in each experiment.
Isolation of extracellular matrix proteins
Extracellular matrix proteins were isolated as previously
described (Wu et al., 1993, 1995). Briefly, cell monolayers
were harvested with a cell scraper and pelleted by centrif-
ugation. The extracellular matrix fraction was isolated by
sequential extraction of the cells with the following: first,
3% Triton X-100 in 10 mM Tris buffer (pH 8.0) containing
150 mM NaCl and protease inhibitors; second, DNase I
(100 g/ml) in 50 mM Tris–HCl (pH 7.4) containing 10
mM MnCl2 and 1 M NaCl; third, 2% sodium deoxycholate
in 50 mM Tris–HCl (pH 8.8) containing 10 mM EDTA. The
deoxycholate-insoluble extracellular matrix fractions were
analyzed by immunoblotting with antibodies recognizing
laminin, fibronectin, and entactin, respectively.
Northern blotting
RNA was isolated from C2C12 cells by using an RNA-
easy mini kit (Qiagen) following the manufacturer’s proto-
col. The isolated RNA (5 g) was separated on a 1%
agarose gel containing formaldehyde. RNA was transferred
to Hyond N nylon membrane (Amersham Phamacia). A
708-bp paxillin cDNA fragment encoding paxillin residues
322–557 was prepared as previously described (Tu et al.,
1999). The paxillin cDNA fragment (25 ng) was labeled
with 32P-CTP using a Random Primed DNA Labeling Kit
(Boehringer Mannhem, Indianapolis, IN). The blot was pre-
hybridized with Express Hyb Hybridization solution
(CLONTECH) at 68°C for 1 h and then hybridized with the
32P-labeled paxillin probe for 3 h at 68°C. Messenger RNA
bands hybridized with the 32P-labeled paxillin probe were
visualized by autoradiography. In control experiments, the
same membrane was probed with a 32P-labeled -actin
cDNA probe to confirm the equal loading.
Results
MIBP interacts with 7B1 integrin but not 51
integrin in C2C12 myoblasts
We previously reported that MIBP specifically interacts
with the sequence LIWKLLMIIHDRREFAKFEKEKM-
NAKWDT in the membrane-proximal region of the 1
cytoplasmic domain (Li et al., 1999). In this study, we tested
the ability of MIBP to associate with 1 integrin chains
paired either with 7B or with 5 that are expressed by
myoblasts and that are known to play important roles in
myogenesis. To facilitate immunoprecipitation of MIBP, we
expressed an epitope-tagged MIBP (FLAG-MIBP) in
C2C12 cells (Fig. 1C, lane 4). FLAG-MIBP was precipi-
tated from the cell lysates with a monoclonal anti-FLAG
antibody M2 (Fig. 1C, lane 6) but not with an irrelevant
mouse IgG (Fig. 1C, lane 5). Immunoblotting analyses of
the immunoprecipitates with antibodies specific for 1 (Fig.
1D, lane 6) and 7B (Fig. 1A, lane 6) revealed that a
fraction of 7B1 integrin was coprecipitated with FLAG-
MIBP. In contrast, despite the presence of 5 integrin in the
cell lysates that could be readily detected by anti-5 anti-
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bodies (Fig. 1B, lane 4), no 5 was detected in the FLAG-
MIBP immunoprecipitate (Fig. 1B, lane 6). In control ex-
periments, none of the integrins were detected in the
precipitates obtained with the irrelevant mouse IgG (Fig.
1A, B, and D, lane 5) or in the precipitates derived from the
vector control cells lacking FLAG-MIBP (Fig. 1A–D, lanes
2 and 3), confirming the specificity of the assays. In the
converse experiment, a fraction of MIBP was coimmuno-
precipitated with FLAG-7 integrin (Fig. 1E). Taken to-
gether, these results indicate that MIBP is capable of form-
Fig. 1. MIBP associates with the 7B1 integrin but not the 51 integrin. (A–D) Lysates of the C2C12 cells transfected with a FLAG-MIBP expression
vector (lanes 4–6) or a mock control vector (lanes 1–3) were incubated with beads conjugated with mouse monoclonal anti-FLAG antibody M2 (lanes 3 and
6) or an irrelevant mouse IgG (lanes 2 and 4). Immunoprecipitation was performed as described in Materials and methods. Proteins in the immunoprecipitates
were resolved in the reducing SDS-PAGE and analyzed by immunoblotting with an antibody specific for the cytoplasmic domain of 7B integrin (A), an
antibody specific for the cytoplasmic domain of 5 integrin (B), an anti-FLAG antibody (C), and an anti-1 integrin antibody (D), respectively. Lanes 1 and
4 were loaded with cell lysates (10 g/lane) as indicated in the figure. Full-length 7B and 5 integrins and their cleavage products containing 7B or 5
cytoplasmic domain, FLAG-MIBP, and 1 integrin are marked. Uncleaved 7B and 5 migrate at approximately 120 and 130 kDa, respectively. (E) Lysates
of C2C12 cells transfected with a FLAG-7BX2 expression vector (lane 2) or the parental C2C12 cells (lane 1) were immunoprecipitated with mouse
monoclonal anti-FLAG antibody M2 and probed with anti-MIBP antibody. The immunoprecipitates from the lysates of the parental C2C12 cells (lane 3),
the FLAG-7BX2 transfectants (lane 4), or a control transfectants lacking FLAG-7BX2 (lane 5), and the supernatants from the parental C2C12 cells (lane
6) and the FLAG-7BX2 transfectants (lane 7) were separated on SDS-PAGE. Note that MIBP was detected in the FLAG-7 immunoprecipitates (lane 4)
but not the control precipitates (lanes 3 and 5), and the amount of MIBP that remained in the supernatant of the FLAG-7BX2 transfectants (lane 7) was
reduced compared with that of the control (lane 6), suggesting that a fraction of MIBP forms a complex with the 7BX21 integrin.
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ing a complex with 1 integrin paired with the 7B integrin
but not with 1 integrin paired with the 5 integrin in
C2C12 myoblasts.
MIBP regulates cell adhesion to laminin but not to
fibronectin
The adhesion of myoblasts to laminin is mediated to a
large extent by the 7B1 integrin (Crawley et al., 1997;
Song et al., 1993; Yao et al., 1996a). The observation that
MIBP recognizes the 7B1 integrin (Fig. 1) prompted us
to test whether MIBP plays a role in the regulation of cell
adhesion to laminin. The parental C2C12 cells, as shown in
previous studies (Yao et al., 1996a), adhered to laminin
(Fig. 2A). Overexpression of MIBP by transfecting the
C2C12 cells with a FLAG-MIBP expression vector signif-
icantly reduced cell adhesion to laminin (Fig. 2A). By
contrast, no reduction of adhesion to laminin was observed
in C2C12 cells transfected with a control FLAG vector
lacking the MIBP sequence (Fig. 2A). To test whether the
overexpression of MIBP globally reduces the adhesiveness
of the cells, we measured the adhesion of the cells express-
ing different levels of MIBP to fibronectin. The results
showed that cell adhesion to fibronectin was not altered by
the overexpression of FLAG-MIBP of FLAG-MIBP (Fig.
2B). Thus, consistent with its selective binding activity
toward the laminin receptor 7B1 integrin, MIBP is in-
volved in the regulation of cell adhesion to laminin but not
to fibronectin.
MIBP regulates the deposition of laminin, but not
fibronectin, into extracellular matrix
Recent studies have demonstrated that integrins not only
mediate cell adhesion to matrix proteins but also participate
in the deposition of extracellular matrix (Colognato et al.,
1999; Sasaki et al., 1998; Schwartz et al., 1995; Schwarz-
bauer, 1999; Stephens et al., 1995; Wu, 1997). Because
MIBP interacts with the laminin receptor 7B1 integrin
and inhibits cell adhesion to laminin, we sought to deter-
mine whether MIBP exerts an effect on the deposition of
laminin into extracellular matrix. To do this, we isolated
extracellular matrices from C2C12 cells that overexpress
MIBP as well as the parental C2C12 and the FLAG vector
control cells. Immunoblotting analyses of the extracellular
matrices with antibodies recognizing laminin 1 chain
showed that approximately fivefold less laminin was incor-
porated into the extracellular matrix in the C2C12 cells
overexpressing FLAG-MIBP (Fig. 3A and D). Probing the
same samples with an anti-fibronectin antibody or an anti-
entactin antibody showed that the amounts of fibronectin
(Fig. 3B and E) or entactin (Fig. 3C) in the extracellular
matrix were not significantly altered, indicating that the
decrease of laminin in the extracellular matrix is not caused
by a general reduction of extracellular matrix. In further
experiments, we analyzed the total cellular level of laminin
in C2C12 cells expressing different levels of MIBP. The
level of cellular laminin was slightly reduced in cells over-
expressing MIBP (Fig. 4A and B). The reduction of the total
cellular level of laminin, however, was much smaller than
the reduction of laminin matrix resulting from overexpres-
sion of MIBP (Fig. 3D).
MIBP suppresses the expression of 7A integrin
We previously showed that MIBP is abundantly ex-
pressed in myoblasts and that MIBP expression is dramat-
ically downregulated after initiation of terminal myogenic
differentiation (Li et al., 1999). By contrast, although
7B1 integrin, to which MIBP binds (Fig. 1), is expressed
throughout myogenic differentiation, the 7A1 integrin is
expressed only after the initiation of myogenic differentia-
tion (Collo et al., 1993; Song et al., 1993; Ziober et al.,
1993). To test whether the downregulation of MIBP and the
induction of the 7A integrin during myogenic differentia-
tion are tightly coupled to each other, we analyzed the
expression of 7A integrin in C2C12 cells overexpressing
FLAG-MIBP by immunoblotting with an antibody specifi-
cally recognizing the 7A cytoplasmic domain. As ex-
pected, 7A was not expressed in the parental C2C12 cells
or the C2C12 cells overexpressing FLAG-MIBP that were
cultured in the growth medium (Fig. 5A, lanes 1, 5, and 9).
The expression of 7A in the parental C2C12 cells was
markedly increased within several days after switching the
medium to the differentiation medium (Fig. 5A, lanes 3 and
4). By contrast, no 7A integrin was detected in C2C12
cells overexpressing FLAG-MIBP under the identical ex-
perimental conditions (Fig. 5A, lanes 7, 8, 11, and 12).
Thus, overexpression of MIBP inhibits the expression of the
7A integrin, suggesting that the downregulation of MIBP
during myogenic differentiation is indeed necessary for
myogenic differentiation and the induction of 7A integrin.
Fig. 2. MIBP inhibits cell adhesion to laminin but not to fibronectin.
Percentage of cells adhering to laminin (A) or fibronectin (B) was deter-
mined as described under Materials and methods. Parental C2C12 cells
(C2C12), C2C12 cells transfected with a control FLAG vector lacking the
MIBP sequence (FLAG), and C2C12 transfectants that stably express
FLAG-MIBP (MIBP) were used. The bars represent the mean values 
S.D. from three separate experiments. In each experiment, five independent
FLAG- MIBP expressing clones (E3.11, D9.8, B3, C4, and D4) were used.
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The 7A and B isoforms are synthesized from the same
7 gene from transcripts generated by alternative RNA
splicing (Collo et al., 1993; Song et al., 1993; Ziober et al.,
1993). To test whether the expression of 7B is also regu-
lated by MIBP during myogenic differentiation, we ana-
lyzed the expression of 7B in the MIBP-overexpressing
C2C12 cells that were cultured in growth medium and in
differentiation medium, respectively. The results showed
that, unlike the expression of the 7A integrin, the expres-
sion of the 7B integrin was not altered in the C2C12 cells
overexpressing FLAG-MIBP (Fig. 5B). The inhibition of
7A expression in cells overexpressing MIBP most likely
reflects MIBP-induced inhibition of myogenic differentia-
tion and the absence of developmentally regulated alterna-
tive splicing essential to generate the 7A transcripts.
MIBP regulates both the protein level and tyrosine
phosphorylation of paxillin
We next sought to identify intracellular signaling inter-
mediates that are regulated by MIBP. Previous studies by
Sastry et al. demonstrated that both the expression level and
Fig. 3. MIBP inhibits the deposition of laminin, but not that of fibronectin, into extracellular matrix. Extracellular matrix proteins were isolated from parental
C2C12 cells (lane 1), control C2C12 cells transfected with a FLAG vector lacking the MIBP sequence (lane 2), and C2C12 cells stably expressing
FLAG-MIBP (lanes 3–6) as described in Materials and methods. The samples were analyzed by immunoblotting with antibodies recognizing the 1 subunit
of laminin (A), fibronectin (B), and entactin (C), respectively. Each lane was loaded with extracellular matrix proteins isolated from equal amount of cellular
proteins (corresponding to 20 g of the 3% Triton X-100 extractable proteins). We have repeated the experiments three times and similar results were
obtained. The relative amounts of extracellular matrix laminin and fibronectin were estimated by densitometric analysis and presented in (D) and (E). The
bars represent the mean values  S.D. from three separate experiments.
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tyrosine phosphorylation of paxillin are critical to the deci-
sion making process of myogenic differentiation (Sastry et
al., 1999). To begin to test whether paxillin is regulated by
MIBP, we compared the level of paxillin in C2C12 cells that
express different levels of MIBP. Immunoblotting analyses
of the total cell lysates showed that cells overexpressing
FLAG-MIBP (Fig. 6A, lanes 2–5) expressed a higher level
of paxillin than the control transfectants (Fig. 6A, lane 1)
and the parental C2C12 cells (not shown). Consistent with
the immunoblotting results, more paxillin was immunopre-
cipitated from the cells overexpressing FLAG-MIBP (Fig.
7A). To estimate the relative level of paxillin in cells over-
expressing FLAG-MIBP, we adjusted the amounts of sam-
ples loaded onto each lane. The results showed that over-
expression of FLAG- MIBP resulted in an approximate
threefold increase of the protein level of paxillin (Fig. 7B).
In marked contrast to paxillin, the level of FAK was not
significantly altered by overexpression of FLAG-MIBP
(Fig. 6B). These results suggest that paxillin is a specific
target regulated by MIBP. To further analyze this, we com-
pared paxillin mRNA levels in cells that express different
levels of MIBP. Northern blotting analyses showed that the
amount of the paxillin transcript was not significantly in-
creased by overexpression of MIBP (Fig. 8), suggesting that
the elevation in paxillin protein is caused primarily by an
upregulation at the translation or posttranslation level.
To test whether MIBP plays a role in the modulation of
tyrosine phosphorylation of paxillin, we analyzed paxillin im-
munoprecipitates from cells expressing different levels of
MIBP. Tyrosine-phosphorylated paxillin was detected by im-
munoblotting with an anti- phosphotyrosine antibody. The
results show that the level of tyrosine phosphorylation of pax-
illin is significantly increased in the cells overexpressing
FLAG-MIBP (Fig. 7C). Higher levels of tyrosine phosphory-
Fig. 5. Overexpression of MIBP suppresses 7A integrin expression. The
parental C2C12 cells (lane 1–4) and FLAG-MIBP-overexpressing C2C12
transfectants E3.11 (lanes 5–8) and B3 (lane 9–12) were cultured in DMEM
containing 10% FBS (lanes 1, 5, and 9) or DMEM containing 2% horse serum
for 2 days (lanes 2, 6, and 10), 4 days (lanes 3, 7, and 11), or 6 days (lanes 4,
8, and 12). The 7A and 7B integrins were detected by immunoblotting (10
g cell lysate/lane) with antibodies specific for the cytoplasmic domains of
7A (A) or 7B (B). The cleavage products of 7A and 7B subunits
containing the cytoplasmic domains are marked in the figure.
Fig. 4. Immunoblotting analysis of total cellular laminin. The parental
C2C12 cells (lane 1), control C2C12 cells transfected with a FLAG vector
lacking the MIBP sequence (lane 2), and the C2C12 cells stably expressing
FLAG-MIBP as indicated in the figure (lanes 3–6) were extracted with 1%
SDS in PBS (pH 7.4). (A) Laminin in the SDS cell extracts was detected
by immunoblotting with an anti-laminin 1 antibody (20 g cellular
proteins/lane). (B) The total laminin synthesized by the FLAG-MIBP-
expressing cells were quantified by densitometric analysis and compared
with those of the parental C2C12 cells and FLAG vector control cells (total
laminin synthesized by the parental C2C12 cells  100%). Four indepen-
dent FLAG-MIBP-expressing C2C12 clones (E3.11, D9.8, B3, and D4)
were analyzed. The bar of “MIBP” represents the mean value  S.D.
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lation were detected even after adjusting the loading amount of
the samples (Fig. 7D). In parallel experiments, we found that
overexpression of MIBP did not alter the tyrosine phosphory-
lation of FAK (Fig. 9). We conclude from these experiments
that both the protein level and the tyrosine phosphorylation of
paxillin, but not FAK, are upregulated by MIBP.
Discussion
Myogenic differentiation is a highly regulated process that
is controlled by multiple factors, including extracellular matrix,
transmembrane receptors, and intracellular signaling mole-
cules (Sastry and Horwitz, 1996; Gullberg et al., 1998; Burkin
and Kaufman, 1999). In a previous study, we found that the
expression of MIBP is dramatically decreased during terminal
myogenic differentiation (Li et al., 1999). The downregulation
of MIBP expression is critical to the progression of terminal
myogenic differentiation, as expression of an epitope-tagged
MIBP under a promoter that is not subject to regulation in
muscle cells suppresses terminal myogenic differentiation. Al-
though the results from previous studies have indicated that the
expression level of MIBP is a crucial element in the decision-
making process of terminal myogenic differentiation, it was
not known how an elevation in the expression of MIBP inhibits
this stage of muscle development. In this study, we have
addressed several questions that are important to the under-
standing of the mechanism by which MIBP regulates terminal
myogenic differentiation.
The first question is whether the interaction between
MIBP and the 1 integrin is regulated by  subunits that
are associated with the 1 integrin. This is important
because 1 integrin chains pair with different  subunits
and these heterodimers have different and even contrast-
ing roles in the regulation of myogenic differentiation
(Sastry et al., 1996, 1999). We have focused on the
7B1 and the 51 integrin in this study, as they are the
predominant integrin receptors for laminin and fibronec-
tin, respectively, in C2C12 myoblasts (Yao et al., 1996b;
Ziober and Kramer, 1996). Our results show that MIBP
associates with the 7B1 integrin but not with 51
integrin. Thus, although the MIBP recognition sequence
LIWKLLMIIHDRREFAKFEKEKMNAKWDT (Li et al.,
1999), which is localized in the membrane-proximal re-
gion of the 1 cytoplasmic domain, is present in both the
7B1 and the 51 integrins, only the one in the
7B1 integrin is available for MIBP binding. How the
presence of 5 inhibits the MIBP-1 interaction is cur-
rently not known. Because there is evidence suggesting
that the cytoplasmic domains of the  and  subunits can
directly interact with each other (Calderwood et al.,
2000; Haas and Plow, 1996; Muir et al., 1994), one
interesting possibility is that 5 inhibits the MIBP-1
association through a direct interaction with the 1 cy-
toplasmic domain. Alternatively, the 5 cytoplasmic do-
main could influence the MIBP-1 interaction through an
Fig. 6. Overexpression of MIBP increases the cellular level of paxillin
protein. C2C12 cells that were transfected with a FLAG vector lacking the
MIBP sequence (lane 1) and the FLAG-MIBP-overexpressing cells E3.11
(lane 2), D9.8 (lane 3), B3 (lane 4), and D4 (lane 5) were extracted with 1%
SDS in PBS. The cell lysates (5 g/lane) were analyzed by immunoblotting
with anti-paxillin antibody (A) and anti-FAK antibody (B), respectively.
Fig. 7. Overexpression of MIBP promotes tyrosine phosphorylation of paxillin
(A, C) Paxillin was immunoprecipitated from equal amounts of cell lysates
derived from the FLAG vector control cells (lane 1) or the FLAG-MIBP-
overexpressing cells E3.11 (lane 2), D9.8 (lane 3), B3 (lane 4), and D4 (lane
5) as described in Materials and methods. Equal amounts of the immunopre-
cipitates were loaded in each lane and analyzed by immunoblotting with
anti-paxillin antibody (A) and anti-phosphotyrosine antibody (C), respectively.
(B, D) The samples were analyzed as described above except that lanes 2 and
3 were loaded with one third of the sample as that in lane 1.
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indirect mechanism. For example, it could recruit other
proteins that are incompatible with MIBP binding to the
integrin cytoplasmic domains.
The second question we addressed is whether MIBP
plays a role in the regulation of cell–matrix adhesion. The
results from this study show that a high expression level of
MIBP reduces cell adhesion to laminin but not to fibronec-
tin. Because the adhesion of myoblasts to laminin promotes
myogenic differentiation, the reduction in the cell adhesion
to laminin is likely responsible, at least in part, for the
suppression of myogenic differentiation induced by the
overexpression of MIBP. Previous experiments have shown
that 71, and 61 to a lesser extent, mediate the adhesion
of myoblasts to laminin (Crawley et al., 1997; Yao et al.,
1996a). While 7 integrin was coimmunoprecipitated with
FLAG-MIBP (Fig. 1), we have failed to detect 6 integrin
in the FLAG-MIBP immunoprecipitates (J.L. and C.W,
unpublished observations). Thus, the simplest explanation
for the inhibitory effect of MIBP on cell adhesion to laminin
is that it results from a specific binding of MIBP to the
7B1 integrin. This is consistent with the observation that
overexpression of MIBP reduced but did not eliminate cell
adhesion to laminin (Fig. 2A). One consequence of this
might be to alter integrin-mediated regulation of intracellu-
lar calcium levels (Kwon et al., 2000). However, we cannot
rule out at this time the possibility that the inhibition of cell
adhesion to laminin is mediated by other (and yet to be
identified) activities of MIBP. We are currently mapping the
site of MIBP that is involved in the interaction with the
7B1 integrin, which should help us to test this hypothesis
in future studies.
Another important and perhaps related finding of this study
is that MIBP inhibits the deposition of laminin but not fi-
bronectin into the extracellular matrix, suggesting that the
deposition of different constituents of extracellular matrix can
be selectively regulated. Given the opposing effects of laminin
and fibronectin on terminal myogenic differentiation, this
would allow the cells to precisely control the progression of the
terminal myogenic differentiation. The deposition of laminin
into the extracellular matrix is regulated by, among other
things, cell surface 71 integrin (Colognato et al., 1999).
Thus, one plausible mechanism by which MIBP regulates
laminin matrix deposition is through its interaction with the
7B1 integrin. This is further supported, although not
proven, by the finding that fibronectin matrix deposition, a
process that is mediated primarily by cell surface 51 inte-
grin (Akiyama et al., 1989; Darribere et al., 1990; Fogerty et
al., 1990; Wu et al., 1993) (to which MIBP does not bind), is
not affected by MIBP. Reduction of laminin in the extracellu-
lar matrix has been implicated in the pathogenesis of specific
forms of congenital muscular dystrophies. In certain cases of
congenital muscular dystrophies, the reduction is caused by
mutations in the laminin genes (Colognato et al., 1999; Hel-
bling-Leclerc et al., 1995; Hillaire et al., 1994; Kuang et al.,
1998; Miyagoe et al., 1997; Sunada et al., 1994, 1995; Wewer
and Engvall, 1996; Xu et al., 1994). However, in some other
cases of congenital muscular dystrophies, this is caused by
mutations in other uncharacterized genes (Hayashi et al., 1993;
Higuchi et al., 1994; Li et al., 1997; Sewry et al., 1997; Wewer
et al., 1995), which likely affect laminin synthesis or matrix
deposition. The finding that the deposition of laminin matrix is
modulated by MIBP raises an interesting possibility that alter-
ation of MIBP expression could contribute to the pathogenesis
of certain forms of muscular dystrophies. In this regard, it is
interesting to note that the reduced level of 7 integrin has also
been associated with laminin-related muscular dystrophies
(Hodges et al., 1997; Vachon et al., 1997).
Several intracellular signaling proteins including FAK
and paxillin have been identified as key components of
the integrin-signaling pathway that regulates myogenic
Fig. 8. Northern blotting analyses of paxillin transcript expressed by C2C12
cells expressing different levels of MIBP. Equal amounts of total RNA (5
g/lane) isolated from the FLAG vector control cells (lane 1) and FLAG-
MIBP-overexpressing cells E3.11 (lane 2) and B3 (lane 3) were separated on
a 1% denaturing gel and transferred to nylon membrane. (A) The membrane
was probed with a 32P-labeled paxillin cDNA probe as described in Materials
and methods. (B) The same membrane was reprobed with a 32P-labeled actin
cDNA probe to confirm the equal loading. Transcripts hybridized with the
32P-labeled cDNA probes were visualized by autoradiography.
Fig. 9. Overexpression of MIBP does not alter tyrosine phosphorylation of
FAK FAK was immunoprecipitated from equal amounts of cell lysates
derived from the FLAG vector control cells (lane 1) or the FLAG-MIBP-
overexpressing cells E3.11 (lane 2) and B3 (lane 3) as described in
Materials and methods. Equal amounts of the immunoprecipitates were
loaded to each lane and analyzed by immunoblotting with anti-FAK anti-
body (A) and anti- phosphotyrosine antibody (B), respectively.
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differentiation (Sastry et al., 1999). An elevation of the
protein level or tyrosine phosphorylation of either protein
shifts the balance from differentiation to proliferation.
The third question we addressed in this study is whether
MIBP plays a role in the regulation of the level or
tyrosine phosphorylation of FAK and paxillin. Our re-
sults indicate that both the protein level and tyrosine
phosphorylation of paxillin are regulated by MIBP. In
contrast, neither the protein level nor tyrosine phosphor-
ylation of FAK is altered by MIBP. Thus, paxillin, but
not FAK, functions as an intracellular target regulated by
MIBP. It is important to note that our results do not rule
out a role of FAK that is upstream, or in parallel, of
MIBP in the regulation of myogenic differentiation. Nev-
ertheless, our results do suggest that the expression and
tyrosine phosphorylation of paxillin and FAK can be
separately regulated, a phenomenon that has also been
observed in integrin-induced FAK and paxillin signaling
in quail myoblasts (Sastry et al., 1999).
In summary, the results presented in this report provide
new evidence that MIBP has an important role in the cel-
lular regulation of myogenic differentiation. Furthermore,
they shed light on the mechanism by which MIBP functions
in this process. Because the level of MIBP expression itself
is regulated by soluble factors in the serum (Li et al., 1999),
the effects of MIBP on cell–matrix interactions and signal-
ing described in this report suggest that MIBP may be part
of a pathway that coordinates signals from soluble growth
factors and the extracellular matrix during myogenic differ-
entiation.
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